SEC Form D · filed December 29, 2023
Lyndra Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
Jessica G. Ballinger · Watertown, MAExec · DirectorAmy Schulman · Watertown, MADirectorZafi S. Avnur · Watertown, MADirectorAshish S. Singh · Watertown, MADirectorCarlo G. Traverso · Watertown, MADirectorPatricia S. Hurter · Watertown, MADirectorHelene S. Madonick · Watertown, MADirectorRobert S. Langer · Watertown, MADirectorCatherine S. Reynolds · Watertown, MADirectorDoug S. Dachille · Watertown, MADirectorLaSalle Investment Management, Inc · Chicago, ILDirectorMichael H. Richardson · ST. HELIER, Y9DirectorTodd Wheatley · Lowell, MADirectorMatthew L. Gefter · Austin, TXDirectorAdrienne Becker · New York, NYDirectorDestry Witt · Madison, WIDirectorJonathan Bombaci · Lowell, MADirectorBakhtear Talukdar · Madison, WIExec · DirectorJLL Exchange TRS, LLC · Chicago, ILDirectorMatthew Perimian · Lowell, MADirectorAP GPE X GP Limited Partnership · Boston, MADirectorRichard Kane · Boston, MADirectorTimothy J. Ozanne · Bozeman, MTDirectorVikas L. Agrawal · ANN ARBOR, MIDirectorSergil R. Naviwala · Atlanta, GADirectorAnthony R. Tittanegro · Atlanta, GAExec · DirectorPatrick R. Leardo · Atlanta, GADirectorPeter Mallouk · Overland Park, KSDirectorCarlyon J. Knight-Evans · Hong Kong, Hong KongDirectorChristopher P. Nash · Hong Kong, Hong KongDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗